![](/img/cover-not-exists.png)
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer
Telli, M. L., Timms, K. M., Reid, J. E., Hennessy, B., Mills, G. B., Jensen, K. C., Szallasi, Z., Barry, W. T., Winer, E. P., Tung, N., Isakoff, S. J., Ryan, P. D., Greene-Colozzi, A., Gutin, A., SangLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-15-2477
Date:
March, 2016
File:
PDF, 382 KB
english, 2016